Oscar Health (OSCR) to Release Quarterly Earnings on Wednesday

Oscar Health (NYSE:OSCR) is scheduled to announce its earnings results before the market opens on Wednesday, August 7th. Analysts expect the company to announce earnings of $0.12 per share for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Tuesday, May 7th. The company reported $0.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.34. The company had revenue of $2.14 billion during the quarter, compared to the consensus estimate of $1.99 billion. Oscar Health had a negative net margin of 0.82% and a negative return on equity of 5.77%. The company’s revenue for the quarter was up 45.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted ($0.18) earnings per share. On average, analysts expect Oscar Health to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Oscar Health Trading Down 1.8 %

Shares of NYSE:OSCR opened at $16.41 on Tuesday. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.29. The company’s 50-day moving average price is $17.57 and its 200 day moving average price is $16.69. The company has a market cap of $3.89 billion, a PE ratio of -41.03 and a beta of 1.61. Oscar Health has a fifty-two week low of $4.72 and a fifty-two week high of $23.44.

Insider Transactions at Oscar Health

In related news, EVP Alessandrea C. Quane sold 25,550 shares of the company’s stock in a transaction that occurred on Monday, June 3rd. The shares were sold at an average price of $19.46, for a total value of $497,203.00. Following the completion of the sale, the executive vice president now owns 237,347 shares in the company, valued at approximately $4,618,772.62. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, EVP Alessandrea C. Quane sold 25,550 shares of the stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $19.46, for a total value of $497,203.00. Following the completion of the sale, the executive vice president now directly owns 237,347 shares of the company’s stock, valued at approximately $4,618,772.62. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Victoria Baltrus sold 7,674 shares of the company’s stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $19.46, for a total value of $149,336.04. Following the completion of the transaction, the chief accounting officer now owns 127,754 shares in the company, valued at approximately $2,486,092.84. The disclosure for this sale can be found here. Insiders have sold 81,655 shares of company stock valued at $1,589,006 over the last three months. Company insiders own 25.11% of the company’s stock.

Analyst Ratings Changes

OSCR has been the topic of several analyst reports. The Goldman Sachs Group raised their target price on Oscar Health from $16.00 to $21.00 and gave the company a “neutral” rating in a research report on Thursday, May 9th. Wells Fargo & Company lifted their price objective on shares of Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a research note on Wednesday, June 12th. Bank of America reiterated a “neutral” rating and issued a $21.00 target price (down previously from $25.00) on shares of Oscar Health in a research report on Thursday, May 30th. Piper Sandler reaffirmed an “overweight” rating and issued a $25.00 price target on shares of Oscar Health in a research note on Wednesday, July 10th. Finally, Baird R W raised Oscar Health to a “strong-buy” rating in a research note on Thursday, May 30th. Three analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $19.75.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.